Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone

References

• LiebermanJAPerkinsDBelgerAThe early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approachesBiol Psychiatry2001501188489711743943
   PubMed Web of Science ®Google Scholar
• LlorcaPMPartial compliance in schizophrenia and the impact on patient outcomesPsychiatry Res2008161223524718849080
   PubMed Web of Science ®Google Scholar
• RobinsonDGWoernerMGAlvirJMJBilderRMHinrichsenGALiebermanJAPredictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorderSchizophr Res2002572–320921912223252
   PubMed Web of Science ®Google Scholar
• BirchwoodMToddPJacksonCEarly intervention in psychosis. The critical period hypothesisBr J Psychiatry Suppl19981723353599764127
   PubMedGoogle Scholar
• AcostaFJBoschESarmientoGJuanesNCaballero-HidalgoAMayansTEvaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variablesSchizophr Res20091072–321321718849150
   PubMed Web of Science ®Google Scholar
• BodénRBrandtLKielerHAndersenMReutforsJEarly non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorderSchizophr Res20111331–3364121982098
   PubMed Web of Science ®Google Scholar
• MisdrahiDPetitMBlancOBayleFLlorcaPMThe influence of therapeutic alliance and insight on medication adherence in schizophreniaNord J Psychiatry2012661495421830849
   PubMed Web of Science ®Google Scholar
• VelliganDIWeidenPJSajatovicMThe expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessJ Clin Psychiatry200970Suppl 4146 quiz 47–4819686636
   PubMed Web of Science ®Google Scholar
• NovickDHaroJMSuarezDPerezVDittmannRWHaddadPMPredictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaPsychiatry Res20101762–310911320185182
   PubMed Web of Science ®Google Scholar
• WeidenPGlazerWAssessment and treatment selection for “revolving door” inpatients with schizophreniaPsychiatr Q19976843773929355136
   PubMed Web of Science ®Google Scholar
• FleischhackerWWOehlMAHummerMFactors influencing compliance in schizophrenia patientsJ Clin Psychiatry200364Suppl 16101314680413
   PubMed Web of Science ®Google Scholar
• MohamedSRosenheckRMcEvoyJSwartzMStroupSLiebermanJACross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophreniaSchizophr Bull200935233634618586692
   PubMed Web of Science ®Google Scholar
• RoccaPCrivelliBMarinoFMonginiTPortaleoneFBogettoFCorrelations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophreniaCompr Psychiatry200849217017618243890
   PubMed Web of Science ®Google Scholar
• SchennachRMeyerSSeemüllerFInsight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorderEur Psychiatry201227862563322542652
   PubMed Web of Science ®Google Scholar
• DayJCBentallRPRobertsCAttitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionalsArch Gen Psychiatry200562771772415997012
   PubMed Web of Science ®Google Scholar
• LecomteTSpidelALeclercCMacEwanGWGreavesCBentallRPPredictors and profiles of treatment non-adherence and engagement in services problems in early psychosisSchizophr Res20081021–329530218295458
   PubMed Web of Science ®Google Scholar
• MisdrahiDVerdouxHLançonCBayleFThe 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental healthCompr Psychiatry200950218118519216896
   PubMed Web of Science ®Google Scholar
• WeissKASmithTEHullJWPiperACHuppertJDPredictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disordersSchizophr Bull200228234134912693439
   PubMed Web of Science ®Google Scholar
• LlorcaPMAbbarMCourtetPGuillaumeSLancrenonSSamalinLGuidelines for the use and management of long-acting injectable antipsychotics in serious mental illnessBMC Psychiatry20131334024359031
   PubMed Web of Science ®Google Scholar
• KaplanGCasoyJZummoJImpact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaPatient Prefer Adherence201371171118024265549
   PubMed Web of Science ®Google Scholar
• LeuchtCHeresSKaneJMKisslingWDavisJMLeuchtSOral versus depot antipsychotic drugs for schizophrenia – a critical systematic review and meta-analysis of randomised long-term trialsSchizophr Res20111271–3839221257294
   PubMed Web of Science ®Google Scholar
• LeuchtSHeresSKisslingWDavisJMEvidence-based pharmacotherapy of schizophreniaInt J Neuropsychopharmacol201114226928421208500
   PubMed Web of Science ®Google Scholar
• TiihonenJHaukkaJTaylorMHaddadPMPatelMXKorhonenPA nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophreniaAm J Psychiatry2011168660360921362741
   PubMed Web of Science ®Google Scholar
• GuyWECDEUAssessment Manual for Psychopharmacology— RevisedRockville, MdUSDHEW1976
   Google Scholar
• TargumSDHouserCNorthcuttJLittleJACutlerAJWallingDPA structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trialsAnn Gen Psychiatry2013121223369692
   PubMed Web of Science ®Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
   PubMed Web of Science ®Google Scholar
• KempRHaywardPApplewhaiteGEverittBDavidACompliance therapy in psychotic patients: randomised controlled trialBMJ199631270273453498611831
   PubMed Web of Science ®Google Scholar
• SAS, Institute IncSAS/STAT® Software: Changes and Enhancements Release 8.2Cary NC SAS Inst Inc2001
   Google Scholar
• MeyerJMUnderstanding depot antipsychotics: an illustrated guide to kineticsCNS Spectr201318Suppl 15867 quiz 6824345710
   PubMed Web of Science ®Google Scholar
• BarbuiCKikkertMMazziMAComparison of patient and clinician perspectives in the assessment of antipsychotic medication adherencePsychopathology200942531131719672133
   PubMed Web of Science ®Google Scholar
• HamannJLippMLChrist-ZappSSpellmannIKisslingWPsychiatrist and Patient Responses to Suspected Medication Nonadherence in Schizophrenia Spectrum DisordersPsychiatr Serv201465788188724686753
   PubMed Web of Science ®Google Scholar
• KikkertMJScheneAHKoeterMWMedication adherence in schizophrenia: exploring patients’, carers’ and professionals’ viewsSchizophr Bull200632478679416887889
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• KampmanOLehtinenKCompliance in psychosesActa Psychiatr Scand1999100316717510493082
   PubMed Web of Science ®Google Scholar
• ThomasPAlptekinKGheorgheMMauriMOlivaresJMRiedelMManagement of patients presenting with acute psychotic episodes of schizophreniaCNS Drugs200923319321219320529
   PubMed Web of Science ®Google Scholar
• WittorfAJakobiUBechdolfAThe influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophreniaEur Psychiatry200924425926719200695
   PubMed Web of Science ®Google Scholar
• RossiGFredianiSRossiRRossiALong-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observationsBMC Psychiatry20121212222909285
   PubMed Web of Science ®Google Scholar
• AlhewitiAAdherence to Long-Term Therapies and Beliefs about MedicationsInt J Family Med2014201447959624688792
   PubMedGoogle Scholar
• GattiMEJacobsonKLGazmararianJASchmotzerBKripalaniSRelationships between beliefs about medications and adherenceAm J Health Syst Pharm200966765766419299373
   PubMed Web of Science ®Google Scholar
• CsernanskyJGSchuchartEKRelapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychoticsCNS Drugs200216747348412056922
   PubMed Web of Science ®Google Scholar
• De HertMvan WinkelRWampersMKaneJvan OsJPeuskensJRemission criteria for schizophrenia: evaluation in a large naturalistic cohortSchizophr Res2007921–3687317336500
   PubMed Web of Science ®Google Scholar
• KampmanOLaippalaPVäänänenJIndicators of medication compliance in first-episode psychosisPsychiatry Res20021101394812007592
   PubMed Web of Science ®Google Scholar
• MintzARDobsonKSRomneyDMInsight in schizophrenia: a meta-analysisSchizophr Res2003611758812648738
   PubMed Web of Science ®Google Scholar
• MutsatsaSHJoyceEMHuttonSBBarnesTRRelationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode studyEur Arch Psychiatry Clin Neurosci2006256635636316902732
   PubMed Web of Science ®Google Scholar
• SegarraROjedaNPeñaJLongitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: one-year follow-up from the Eiffel studyEur Psychiatry2012271434920813506
   PubMed Web of Science ®Google Scholar
• CharpentierAGoudemandMThomasPL’alliance thérapeutique, un enjeu dans la schizophrénie [Therapeutic alliance, a stake in schizophrenia]L’Encéphale20083518089 French
   Web of Science ®Google Scholar
• Schennach-WolffRJägerMSeemüllerFAttitude towards adherence in patients with schizophrenia at dischargeJ Psychiatr Res200943161294130119505697
   PubMed Web of Science ®Google Scholar
• StaringABMulderCLDuivenvoordenHJDe HaanLVan der GaagMFewer symptoms vs more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of lifeSchizophr Res20091131273319525092
   PubMed Web of Science ®Google Scholar
• YangJKoYHPaikJWSymptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophreniaSchizophr Res20121342–322623122133906
   PubMed Web of Science ®Google Scholar
• MisdrahiDDelgadoABoujuSCometDChiarinyJFMotifs et délais pour l’initiation de la forme injectable à libération prolongée de la rispéridone : enquête auprès de 399 psychiatres français [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]Encephale201339Suppl 1S8S14 French23541914
   PubMed Web of Science ®Google Scholar